scorecardresearch
Add as a preferred source on Google
Tuesday, November 11, 2025
TopicDr Reddy's

Topic: Dr Reddy's

Using ‘4IR’ tech to beat global challenges — why 4 Indian firms are on WEF’s ‘lighthouses’ list

Cipla, Dr Reddy’s Lab, Mondelez & Unilever lauded for transition to fourth industrial revolution using advanced technologies despite global challenges like Ukraine war & Covid.

Dr. Reddy’s gets emergency use approval from DCGI for Russian vaccine Sputnik Light

Sputnik Light is second Covid vaccine to be made available in India by Dr. Reddy’s. In April 2021, DCGI granted approval to two-dose Sputnik V vaccine for restricted use in India.

Haryana’s tech-based healthcare approach could be a blueprint for our response to Covid-19

A project piloted by Deloitte and the Haryana govt in Karnal district resulted in a significant reduction in the number of fatalities from Covid-19.

Full launch of Sputnik V vaccine in India could take more time, says Dr Reddy’s

Dr Reddy's, through which Russia's Sputnik V is available in India, said the timeline was pushed a little further due to import dependency, quality checks.

Dr Reddy’s announces commercial launch of Covid drug 2-DG, to cost Rs 990/sachet

The drug was developed by DRDO in collaboration with Dr Reddy's and granted emergency use approval on 1 May. It will be supplied to major govt and private hospitals across India.

Not authorised any third party to supply Sputnik V, sole distributor in India: Dr Reddy’s

Dr Reddy's urged everyone to beware of unauthorised individuals offering fake deals or procurement of the Sputnik V vaccine and has has initiated legal action against any entities.

Second batch of Sputnik V vaccine containing 60,000 doses arrives in Hyderabad

Dr Reddy's Laboratories on 14 May soft-launched the Russian Covid vaccine, priced at Rs 948, with 5% GST per dose. The first consignment 1.50 lakh doses had landed on 1 May.

Govt panel rejects emergency-use approval for Dr Reddy’s Russian-origin potential Covid drug

The company had requested for waiver of clinical trials in India as a condition to market the monoclonal, antibody-based drug, Olokizumab.

First batch of Sputnik V vaccine to reach Kanpur medical college for Phase 2, 3 trials

According to officials, the decision to conduct the human clinical trials was taken after Dr Reddy's Laboratories got approval from the Drugs Controller General of India.

Modi govt panel rejects emergency-use approval for Dr Reddy’s potential Covid drug

Originally intended for cancer, Dr Reddy’s 2-DG works by preventing the supply of glucose molecules to cancerous cells, which need glucose for survival. 

On Camera

BBC scandal: Britain’s elite establishment is rapidly sinking

The impact of all this upheaval is unmooring. We search for the BBC to confirm that Britain still exists and find it missing.

India’s factory data may get reality check in MoSPI’s new IIP plan, defunct factories to be dropped

MoSPI proposes to remove closed factories from IIP sample, aiming for truer picture of India’s industrial health in upcoming 2022–23 base series. Plan open to public feedback until 25 November.

‘Let them see’: Putin says new nuclear-powered missiles in the making, in message to Washington

At a ceremony felicitating Russian military engineers, Putin highlights Moscow’s 'parity' in defence technologies for the next century.

Bihar is where politics moves, and everything else stands still

Bihar is blessed with a land more fertile for revolutions than any in India. Why has it fallen so far behind then? Constant obsession with politics is at the root of its destruction.